Search research articles
Contact Us
Filters
Showing results (1-10 of 367) with videos related to
Page
of 37
Sort By:
Journal of the National Cancer Institute. Monographs
|
June 17, 2003
Chapter 11: Future directions in cervical pathology
Mark E Sherman
Oncotarget
|
December 7, 2017
Traceback: leveraging archived biospecimens to identify mutation carriers
Goli Samimi, Mark E Sherman
Journal of the National Cancer Institute
|
October 8, 2013
From Papanicolaou to papillomaviruses: evolving challenges in cervical cancer screening in the era of human papillomavirus vaccination
Mahboobeh Safaeian, Mark E Sherman
Journal of the National Cancer Institute
|
March 12, 2021
BRCA1/2 and Endometrial Cancer Risk: Implications for Management
Mark E Sherman, William D Foulkes
Cancer Prevention Research (Philadelphia, Pa.)
|
January 4, 2024
Leveraging GWAS: Path to Prevention?
Stacey J Winham, Mark E Sherman
Cancer
|
July 2, 2003
Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus
Mark E Sherman, Susan S Devesa
Gynecologic Oncology
|
February 22, 2021
Implications of the obesity epidemic for endometrial cancer risk, mortality, and survivorship
Ashley S Felix, Mark E Sherman
Journal of the National Cancer Institute
|
October 30, 2012
Human papillomavirus vaccines for cervical cancer prevention: translating possibility into reality
Vikrant V Sahasrabuddhe, Mark E Sherman
Oncoscience
|
May 20, 2020
Computational disease progression modeling can provide insights into cancer evolution
Steve Goodison, Mark E Sherman, Yijun Sun
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 15, 2009
Qualitative age interactions in breast cancer studies: mind the gap
William F Anderson, Ismail Jatoi, Mark E Sherman
Page
of 37
Search research articles
Search
Showing results (1-10 of 367) with videos related to
Sort By:
Page
of 37
Journal of the National Cancer Institute. Monographs
|
June 17, 2003
Chapter 11: Future directions in cervical pathology
Mark E Sherman
Oncotarget
|
December 7, 2017
Traceback: leveraging archived biospecimens to identify mutation carriers
Goli Samimi, Mark E Sherman
Journal of the National Cancer Institute
|
October 8, 2013
From Papanicolaou to papillomaviruses: evolving challenges in cervical cancer screening in the era of human papillomavirus vaccination
Mahboobeh Safaeian, Mark E Sherman
Journal of the National Cancer Institute
|
March 12, 2021
BRCA1/2 and Endometrial Cancer Risk: Implications for Management
Mark E Sherman, William D Foulkes
Cancer Prevention Research (Philadelphia, Pa.)
|
January 4, 2024
Leveraging GWAS: Path to Prevention?
Stacey J Winham, Mark E Sherman
Cancer
|
July 2, 2003
Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus
Mark E Sherman, Susan S Devesa
Gynecologic Oncology
|
February 22, 2021
Implications of the obesity epidemic for endometrial cancer risk, mortality, and survivorship
Ashley S Felix, Mark E Sherman
Journal of the National Cancer Institute
|
October 30, 2012
Human papillomavirus vaccines for cervical cancer prevention: translating possibility into reality
Vikrant V Sahasrabuddhe, Mark E Sherman
Oncoscience
|
May 20, 2020
Computational disease progression modeling can provide insights into cancer evolution
Steve Goodison, Mark E Sherman, Yijun Sun
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 15, 2009
Qualitative age interactions in breast cancer studies: mind the gap
William F Anderson, Ismail Jatoi, Mark E Sherman
Page
of 37